ISR Report Provides Insight into Pancreatic Cancer, Clinical Development Pipeline
Informing the drug development and commercialization industry Cary, N.C. – March 27, 2013 – Industry Standard Research (ISR) today announced the release of a new pharmaceutical market research report entitled “Pancreatic Cancer: Disease and Pipeline Analysis” which provides insight into a market with few effective therapies. “ISR’s latest report profiles the pancreatic cancer market because … Continued